Westerdijk Fungal Biodiversity Institute, Utrecht, the Netherlands.
Department of Dermatology, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China.
Med Mycol. 2019 Oct 1;57(7):833-840. doi: 10.1093/mmy/myy148.
Although Cyberlindnera fabinaii is a rare opportunist yeast species, its ability to cause septicemia, produce biofilm, and rapid acquisition of resistance to fluconazole and voriconazole, reinforced the urge for its identification from its closely related species. Widely used biochemical assays mainly identify Cyberlindnera fabinaii as Cyberlindnera jadinii and Wickerhamomyces anomalus, resulting in underestimation of this yeast in clinical settings. Moreover, the urge for a reliable molecular means of identification remains unsolved for 28 years. In order to unequivocally differentiate Cy. fabianii, Cy. mississipiensis, Cy. jadinii, and W. anomalus, we designed a dual-function multiplex polymerase chain reaction (PCR) assay. Challenging our dual-function multiplex PCR assay with 30 most clinically important yeast species, proved its specificity. Although conventional PCR could differentiate four target species, the real-time PCR counterpart due to Tm overlap misidentified Cy. mississipiensis as Cy. jadinii. Alongside of presenting a comprehensive literature review of published cases of Cy. fabianii from 1990 to 2018, we collected various clinical isolates from Tehran, Shiraz, and Fasa (July 1, 2017, to December 31, 2017) to find a passive relative distribution of these closely-related species in Iran. Subjecting our Iranian collection of yeast isolates to matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) MS and LSU and ITS rDNA sequencing revealed six isolates of Cy. fabianii (central venous catheter n = 2 and vaginal swabs n = 4) and one isolate of Cy. jadinii (vaginal swabs). Due to the use of biochemical assays in global ARTEMIS study, we encourage reidentification of clinical isolates of Cy. jadinii and Cy. jadinii using MALDI-TOF or Sanger sequencing that might lead to correcting the distribution of this fungus.
虽然 Cyberlindnera fabinaii 是一种罕见的机会主义酵母,但它能够引起败血症、产生生物膜以及快速获得对氟康唑和伏立康唑的耐药性,这促使人们从其密切相关的物种中对其进行鉴定。广泛使用的生化检测主要将 Cyberlindnera fabinaii 鉴定为 Cyberlindnera jadinii 和 Wickerhamomyces anomalus,导致这种酵母在临床环境中被低估。此外,28 年来,人们一直渴望找到一种可靠的分子鉴定方法。为了明确区分 Cy. fabianii、Cy. mississipiensis、Cy. jadinii 和 W. anomalus,我们设计了一种双功能多重聚合酶链反应(PCR)检测方法。用 30 种最重要的临床酵母种对我们的双功能多重 PCR 检测方法进行了挑战,证明了其特异性。虽然传统 PCR 可以区分四个目标物种,但实时 PCR 由于 Tm 重叠,错误地将 Cy. mississipiensis 鉴定为 Cy. jadinii。在对 1990 年至 2018 年发表的关于 Cy. fabianii 的文献进行全面综述的同时,我们还从德黑兰、设拉子和法萨(2017 年 7 月 1 日至 2017 年 12 月 31 日)收集了各种临床分离株,以发现这些密切相关的物种在伊朗的被动相对分布。将我们从伊朗收集的酵母分离株进行基质辅助激光解吸/电离飞行时间(MALDI-TOF)MS 和 LSU 和 ITS rDNA 测序,结果显示 6 株 Cy. fabianii(中心静脉导管 n = 2,阴道拭子 n = 4)和 1 株 Cy. jadinii(阴道拭子)。由于在全球 ARTEMIS 研究中使用了生化检测方法,我们鼓励使用 MALDI-TOF 或 Sanger 测序重新鉴定 Cy. jadinii 和 Cy. jadinii 的临床分离株,这可能有助于纠正这种真菌的分布。